Concord Wealth Partners’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-200	Closed	-$79.5K	–	227
2025 Q4	$79.5K	Hold	200	–	–	0.01%	279
2025 Q3	$91.2K	Hold	200	–	–	0.01%	264
2025 Q2	$65.2K	Hold	200	–	–	0.01%	312
2025 Q1	$54K	Hold	200	–	–	0.01%	308
2024 Q4	$47.1K	Hold	200	–	–	0.01%	339
2024 Q3	$55K	Hold	200	–	–	0.01%	324
2024 Q2	$48.6K	Buy	+200	New	+$31.6K	0.01%	313
2022 Q3	–	Sell	-17	Closed	-$2K	–	190
2022 Q2	$2K	Sell	17 -111	-87%	-$15.7K	﹤0.01%	985
2022 Q1	$21K	Buy	128 +9	+8%	+$1.37K	0.01%	616
2021 Q4	$20K	Buy	119 +38	+47%	+$7.06K	﹤0.01%	640
2021 Q3	$15K	Buy	81 +31	+62%	+$5.82K	0.01%	415
2021 Q2	$8K	Buy	50 +6	+14%	+$879	﹤0.01%	651
2021 Q1	$6K	Buy	+44	New	+$6.62K	﹤0.01%	642